Lv3
268 积分 2025-06-18 加入
Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1
1个月前
已完结
A Sequential Dual GLP-1R/GIPR Agonist-To-Antagonist Molecule Achieves Superior Weight Loss in Obese Mice
1个月前
已完结
119-0R: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Novel Ultra-Long-Acting GLP-1 Receptor Agonist (ZT002) in Healthy Subjects
1个月前
已完结
Tirzepatide (Mounjaro) for type 2 diabetes
2个月前
已关闭
Liraglutide versus semaglutide for weight reduction—a cost needed to treat analysis
2个月前
已完结
皖公网安备34019202002308
